Anne Marie Biernacki, Executive Vice President, Technology Intelligence Advisor and Director, ICS Advisory Services Corporation Therapeutics Sector, said, "Over the past two years, IC Sciences has been developing the content and finding the knowledge and expertise to deliver via these platforms. We believe that this three-pronged approach of science plus business plus technology is what the field needs to assemble the right combination of offerings to serve diverse and growing needs in the professional, consumer, and therapeutics market sectors."
The IP offerings available to Alliance members, who currently include Revolution Health, Blue Cross Blue Shield of Massachusetts, AthenaHealth, patientslikeme, and others, will be used by clinicians, patients, consumers, payers, and therapeutics manufacturers in myriad strategic and tactical contexts and applications, including patient engagement, collective intelligence among clinician or patient peers, clinical performance management, and therapeutic product support. To learn more about the ICS Advisory Services Intellectual Property offerings available through the ICS Alliance and membership benefits of the Alliance, visit http://www.icsciencesalliance.com. About IC Sciences Corporation IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit: http://www.ICSciences.com.
About Informed Clinical Sciences Advisory Services Corporation
|SOURCE Informed Clinical Sciences Advisory Services Corporation|
Copyright©2008 PR Newswire.
All rights reserved